Sequence analysis of VP4 genes of wild type and culture adapted human rotavirus G1P[8] strains  by Arora, Ritu et al.
541Asian Pacific Journal of Tropical Medicine (2011)541-546
Document heading          doi:  
Sequence analysis of VP4 genes of wild type and culture adapted human 
rotavirus G1P[8] strains
Ritu Arora, Ganesh S Dhale, Pooja R Patil, Shobha D Chitambar*
Enteric Viruses Group, National Institute of Virology, Pune India
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 29 October 2010
Received in revised form 27 April 2011
Accepted 15 May 2011
Available online 20 July 2011
Keywords:
Rotavirus
Cell culture
G1P[8]
VP4 gene
  *Corresponding author:  Dr. Shobha D. Chitambar, Deputy Director & Group Leader, 
Enteric Viruses Group, National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 
- 411 001, India. 
     Tel: 91-020-26127301
     Fax: 91-020-26122669
     E-mail: drshobha.niv@gmail.com
1. Introduction
  Among the diverse pathogens causing diarrhea, rotavirus 
has been established as the most important cause of severe 
diarrhea in children, accounting for an average of 39% of 
severe diarrheal cases [1]. Globally, rotavirus is responsible 
for an estimated 611 000 deaths, 2 million hospitalizations, 
25 million medical visits and a total of 140 million cases 
among children under 5 years of age annually [1].  Mortality 
caused by rotaviruses occurs especially in the countries 
from South Asian region [2]. India alone accounts for 
approximately 122 000-153 000 infant deaths per annum due 
to rotavirus disease [3]. To reduce the burden of rotavirus 
disease, two orally administrable rotavirus vaccines, Rotarix 
(Monovalent, G1P[8]) and RotaTeq (Pentavalent, G1,G2,G3, 
G4 and P[8]), have been developed and licensed in more 
than 100 countries, and were introduced into the routine 
childhood immunization program in some countries in Latin 
America, Europe, Australia, and the United States [4].
  Rotavirus belongs to the family Reoviridae, and is 
characterized by a genome of 11 segments of double-
stranded RNA which encodes six structural (VP1-4, VP6, 
VP7) and six nonstructural viral proteins (NSP1-6) [5]. The 
two outerlayer proteins, VP7 (G, glycoprotein) and VP4 
(P, protease sensitive) form the basis of the current dual 
classification system of group A rotaviruses into G and P 
genotypes, respectively[5].  This classification system has 
enabled identification of rotaviruses into 24 G and 33 P 
types [6,7] revealing >45 distinct G-P combinations [8]. Five 
combinations of G and P genotypes, G1P[8], G2P[4], G3P[8], 
G4P[8] and G9P[8] comprise more than 90% of the human 
rotavirus infections, among which G1P[8] combination 
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prevails, worldwide [9].
  Rotavirus replicates in the mature enterocytes of the 
small intestine, an environment rich in proteases. The 
rotavirus VP4 is a trimeric spike protein involved in the 
cell attachment and membrane penetration[5]. For efficient 
entry into the cell a virion needs to be activated by trypsin. 
Proteolytic cleavage of VP4 primes the virus for efficient 
entry into the cells [5]. During proteolysis, VP4 (88 kDa) 
is cleaved into VP8* (28 kDa) and VP5* (60 kDa), and the 
cleavage products remain associated with the virion. 
The VP8* fragment (247 amino acid, 1-247) is the viral 
hemagglutinin [5], while the VP5* fragment (529 amino acid, 
248-776) is involved in the permeabilization of membranes [5].
The X-ray crystallographic structures of VP8* and VP5* 
have provided strong evidence of the distal globular domain 
of the VP4 spike to be composed of VP8*, with the remaining 
body of the spike consisting of VP5* [10,11].
  The VP8* region has been described to contain four 
putative neutralization domains (8-1, 8-2, 8-3, and 
8-4) defined by amino acid alignments and mapping of 
monoclonal antibody escape mutants [10,11], while VP5* 
fragment  involved in binding to neutralizing antibody has 
not been well characterized. 
  Rotaviruses have been adapted in cell culture, however 
genomic changes during cell culture adaptation have 
been described occasionally [12,13]. The aim of the present 
study was to compare the VP4 gene sequences of cell 
culture adapted G1P[8] rotavirus strains with those of the 
corresponding wild type strains detected in Indian  children. 
2. Materials and methods
2.1. Viruses and cell culture
  The stool specimens collected from children hospitalized 
for acute gastroenteritis in 2005-2007 were tested for the 
presence of rotavirus antigen by enzyme linked immuno 
sorbent assay (ELISA) and characterized by multiplex PCR 
for identification of G and P types [14]. Rotavirus strains with 
G1P[8] specificity were detected predominantly. Thirteen 
specimens indicating high optical density values (>0.8) 
in ELISA and found in sufficient quantity were selected 
for the inoculation in cell culture. The rhesus monkey 
kidney epithelial cell line, MA104 was procured from 
ATCC, USA and grown in rolling tubes containing Eagle’s 
Minimum Essential Medium (MEM) supplemented with 
10% fetal calf serum and antibiotics (Penicillin 200 U/mL
and Streptomycin 20 毺g/mL). The tubes were maintained 
at 37 曟 and inoculated with the fecal specimens containing 
human rotavirus G1P[8] strains, as described earlier [15]. 
Prior to inoculation in the cell line, virus was activated 
by 4μg per mL of trypsin (TPCK Trypsin). At the end of 
1h adsorption period of virus, inoculum was removed and 
maintenance medium containing trypsin (1 毺g/mL) was 
added, and incubation was continued at 37 曟 for 7 days on 
the roller apparatus. The virus was passaged 10 times in the 
cell culture. The cell cultures indicating cytopathic effect 
(CPE) were subjected to two cycles of freezing and thawing 
for the recovery of virus. The culture supernatants were 
stored at -70 曟 until tested. 
2.2. ELISA 
  Antigen capture ELISA was performed on the supernatants 
of infected cell cultures at each passage level using a Group 
A Rotavirus detection kit (IDEIATM Rotavirus, DAKO, USA) 
according to the manufacturer’s protocol. To visualize the 
rotavirus particles under electron microscope, samples were 
examined by negative staining as described earlier [16]. 
2.3 RNA extraction and reverse transcription polymerase 
chain reaction (RT- PCR)
  Viral RNA was extracted from the unpassaged virus 
(30% stool suspension) and supernatants of the infected 
cell cultures at passage level 10 using Trizol, LS reagent 
(Invitrogen, USA) according to the manufacturer’s 
instructions.  The presence of rotavirus RNA was 
determined by RT-PCR based amplification of the VP6 
gene as described previously [17]. All samples indicating 
amplification in VP6 RT-PCR were subjected to full length 
amplification of VP4 genes using a Qiagen One step RT-PCR 
kit (Qiagen, Germany) and primers as described previously [18].
The PCR conditions employed in the study were similar 
to those reported earlier [19]. All of the PCR products 
were electrophoresed in 2% agarose gels containing 
ethidium bromide (0.5 毺g/mL) and visualized under UV 
transilluminator.
2.4. Nucleotide sequencing
  The PCR amplicons were purified using QIAquick 
PCR purification kit (Qiagen, Germany) according to 
the manufacturer’s instructions and sequences in both 
directions were determined by the dideoxy nucleotide 
chain terminator method using a Bigdye Terminator cycle 
sequencing reaction kit V3.1 (Applied Biosystems, USA). 
The sequence data were collected from an automated 
sequencer ABI 3130 XL (Applied Biosystems, USA).
2.5. Sequence and phylogenetic analysis
  The nucleotide and deduced amino acid sequences of the 
VP4 genes of wild type and cell culture adapted rotavirus 
strains were compared with each other and with those of 
reference strains available in the NCBI (National Center for 
Biotechnology Information) GenBank database using BLAST 
(www.ncbi.nlm.nih.gov/blast) server. Multiple alignments 
were carried out using CLUSTAL W.  The phylogenetic 
tree was generated using MEGA 4.0 with neighbor-joining 
algorithm and Kimura 2-parameter distance model. The 
reliability of the analysis was tested by applying bootstrap 
test with 1 000 bootstrap replications [20]. 
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2.6. Sequence submission
  The nucleotide sequences of VP4 genes of the present study 
were submitted to GenBank  under the accession numbers - 
EU984107 and HM467806-HM467808 for wild type strains and 
EU984106 and HM467803- HM467805  for cell culture adapted 
G1P[8] strains.
2.7. Hydropathy Index
  Hopp-Woods scale (a hydrophilic index, with nonpolar 
residues assigned negative values) was used to compare the 
hydrophilic indices of the wild type and cell culture adapted 
rotavirus strains. At each position, the mean hydrophilic 
index of the amino acids within the window was calculated 
and that value was plotted as the midpoint of the window. 
A window size of 9 was used to determine the regions of 
maximal hydrophilicity.
3. Results 
3.1. Virological analysis
  Four (06361, 0613158, 061060 and 0715880) of thirteen 
G1P[8] rotavirus strains propogated in MA104 cell culture 
showed CPE of increasing strength comprising of increased 
granularity and rounding of cells passage 3 onwards.  All 
(4/4) strains showed the presence of rotavirus RNA in RT-
PCR of VP6 gene, however, only three showed positivity in 
ELISA at passage 10. The presence of virus like particles 
of ~70 nm diameter was confirmed by electron microscopy 
(data not shown).  One specimen (0715880- CA) found to be 
negative in ELISA and electron microscopy probably carried 
low viral load at passage 10. The cell culture adapted strains 
corresponding to their wild type strains were designated 
as 06361-CA, 0613158-CA, 061060-CA and 0715880-CA, 
respectively. 
3.2. Phylogenetic analysis 
  Phylogenetically, VP4 genes of all of the wild type and cell 
culture adapted strains of the present study clustered with 
rotavirus strains of P[8]-3 lineage, (Figure 1) with 93.6%-
98.5% nucleotide and 93.8%-98.9% amino acid identity. 
Highest (98.5%) nucleotide identity was displayed with the 
strain, DH396 from Bangladesh. With other P-genotypes the 
nucleotide and amino acid identities shown by these strains 
were 59.8%- 87.4 % and 68.3%-91.2%, respectively.
3.3. Nucleotide and deduced amino acid sequence analysis
  The potential cleavage site, arginine at positions 231, 241, 
and 247, the highly conserved proline residues at positions 
68, 71, 225 and 226 and the conserved cysteine residues 
at positions 216, 318, 380 and 774 described earlier (19,12) 
were identified in all of the VP4 genes of wild type and cell 
culture adapted strains.
Figure 1. Phylogenetic tree constructed from nucleotide sequences of 
VP4 gene of study strains and other representative strains.   
The strains of the present study are underlined. For each strain, the 
following data are given: strain name/ genotype.
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3.4. Nucleotide and amino acid alignment
  The VP4 gene of cell culture adapted strain, 0613158-CA 
showed 99.9% nucleotide and 99.9% amino acid identity 
with its wild type strain, 0613158. One nucleotide mismatch 
(C-T) was observed at position 146 which led to the 
substitution of alanine (A) by valine (V) at position 46 (Table 
1). 
  The cell culture adapted strain, 06361-CA showed 99.8% 
nucleotide and 99.9% amino acid identity with counterpart 
wild type strain, 06361. However, it revealed three 
nucleotide mismatches which included two silent mutations 
(G-A and C-T) at positions 651 and 783 and one (C-G) at 
position 188 generating substitution of amino acid (T-R) at 
position 60 (Table 1).
  The cell culture adapted strain 061060-CA showed 97.3% 
nucleotide and 98.5% amino acid identity with its wild 
type strain, 061060. In contrast to 0613158-CA and 06361-
CA strains, 061060-CA strain revealed numerous nucleotide 
mismatches (n=64) in the VP4 gene. Most of them were silent 
mutations except 12 which replaced amino acids (R-K), 
(S-N), (L-V),  (G-V), (N-S), (P-S), (Q-H), (A-T), (Y-V), (V-L) 
(K-R) and (F-Y) at positions 162, 189, 237, 377, 387, 389, 480, 
586, 587, 600, 616 and 672, respectively (Table 1).
  The cell culture adapted strain 0715880-CA showed 97.2% 
nucleotide and 98.5% amino acid identity with its wild type 
strain, 0715880. Similar to 061060-CA strain, this strain also 
displayed multiple (n=63) nucleotide mismatches in the 
VP4 gene sequence with silent mutations except 13 which 
replaced amino acids at positions 33 (I-V), 104 (V-A), 113 
(D-N), 162 (R-K), 183 (D-A), 586 (A-T), 587 (F-V), 600 (V-L), 
615 (S-G), 616 (K-R), 621 (R-K), 625 (T-P),  and 644 (L-I) 
(Table 1).
3.5. Unique amino acid substitutions in the VP4 genes of 
Indian rotavirus strains
  Unique amino acids defined as the presence of specific 
amino acid residues at specific positions not reported in 
the sequences available in the GenBank were identified 
by using tblastn algorithm available at NCBI website. The 
wild type strains, 061060 and 0715880 showed respectively 
two (V377G and S387N) and one (I644L) unique amino acid 
substitutions. The presence of unique amino acids- valine 
in 0613158-CA, arginine in 06361-CA, valine, serine and 
histidine in 061060-CA and glycine and proline in 0715880-
CA were identified at positions 46, 60, 237, 389, 480, 615 and 
625, respectively (Table 1).  
3.6. Hydrophilicity Index
  As compared to the wild type strains, cell culture adapted 
06361-CA, 061060-CA, and 0715880-CA strains showed 
amino acid substitutions at positions 60, 237/586/587 and 
586/587/615/625 respectively in VP4 protein at pH 7.0 
indicating increase in the hydrophilicity of the protein while 
substitution of A-V at position 60 in 0613158-CA strain 
reduced its hydrophilicity (Figure 2 A-D).
Figure 2. Hydrophilic indices of VP4 protein of (A) 06361 and 06361-CA;  (B) and (C) 061060 and 061060-CA and (D) 0715880 and 
0715880-CA strains. The circle indicates increases in hydrophilicity of the strains.
2.5
2.0
1.5
1.0
0.5
0
-0.5
-1.0
-1.5
2.5
2.0
1.5
1.0
0.5
0
-0.5
-1.0
-1.5
2.5
2.0
1.5
1.0
0.5
0
-0.5
-1.0
-1.5
2.5
2.0
1.5
1.0
0.5
0
-0.5
-1.0
-1.5
0                                                     50                                                  100
500                                                   550                                                 600 550                                                   600                                                 650
100                               150                                200                                250
Wt
CA
Wt
CA
Wt
CA
Wt
CA
D
C
A B
Ritu Arora et al./Asian Pacific Journal of Tropical Medicine (2011)541-546 545
4. Discussion
  The present study reports comparative analysis of the full-
length nucleotide (2354) and deduced amino acid (775) 
sequences of VP4 genes of wild type and cell culture adapted 
G1P[8] rotavirus strains. VP4 gene is known to be associated 
with the cell attachment, penetration, neutralization and 
virulence of rotaviruses [5]. The changes in this gene have 
been described in in vitro studies [13,21]. The amino acid 
substitutions at positions 38 (G-S), 120 (M-T), 421 (S-N), 525 
(D-G) and 618 (L-F) during cell culture adaptation have been 
found to be supportive for cultivation of human rotavirus 
strain, Wa in HepG2 liver cells [21]. The same number of 
amino acid substitutions, however, at different  positions [51 
(G-D),167 (L-F),331 (S-F),385 (D-T) and 695 (N-I)]  have been 
identified in a  study carried out on African green monkey 
kidney cell line unpassaged and 33 times passaged 89-12 
rotavirus strain[21].  
  Recently, a G1P[8] rotavirus strain, MMC71 isolated in 
MA104 cells has shown 100% identity in VP4 gene with its 
wild type counterpart [22]. A rotavirus vaccine candidate, 
CDC-9 after passaging in Vero cells has revealed five amino 
acid substitutions at positions 51, 331, 364, 385 and 388 [13].
The strain, CDC-9 shared two sites (51 and 385) with the 
strain 89-12, however, due to unavailability of sequence data 
of this strain (CDC-9), amino acid substitutions remain to be 
identified. In the present study, the positions (33, 46, 60, 104, 
113, 162, 183, 189, 237, 377, 387, 389, 480, 586, 587, 600, 615, 
616, 621, 625, 644 and 672) of amino acid substitutions in the 
VP4 gene of cell culture adapted strains were different from 
those reported earlier. These data suggest the strain specific/ 
host specific substitutions in the G1P[8] strains during 
cell culture adaptation. Similar observations have been 
made for the hepatitis A, dengue and porcine reproductive 
and respiratory syndrome viruses adapted to cell lines of 
different origins [23-28]. 
  Amino acid substitution identified at position 260 (P-L), 
during in vivo passaging of porcine rotavirus strain, 4F has 
been described to be essential for its replication in piglets [29].
Unique amino acid substitutions- A46V, T60R, L237V/G389V/ 
Q480H and S615G/ T625P identified in the present study may 
be important respectively for the growth of 0613158, 06361, 
061060 and 0715880 strains in MA104 cell culture.  
  All of the G1P[8] study strains showed nucleotide 
substitutions spread over the VP4 gene without revealing 
any specific susceptible site during cell culture adaptation. 
Very recently, it has been demonstrated that a mutation, 
V391D in VP5* region of VP4 protein caused failure in the 
permeabilization process during infection of MA104 cells 
with rotavirus [30]. As a result mutated rotavirus particles 
carried reduced hydrophobicity and found 10 000 fold 
less infectious than those of parent type. In view of this 
observation more substitutions detected in the VP5* region 
of VP4 genes of cell culture adapted G1P[8] rotavirus 
strains of the present study need to be analyzed further for 
conformation and immunogenicity of the VP4 protein and 
finally for the comparative infectivity of the cell culture 
adapted and wild type rotavirus strains. 
  Amino acid substitutions associated with the neutralization 
resistant mutants selected by cross-reactive monoclonal 
antibodies have been described in the VP4 gene at positions 
88,148,305,385,388,392,428,433 and 439 [5]. Such substitutions, 
however, were not identified in wild type and cell culture 
adapted study strains. This data may indicate the potential 
of these strains to elicit the neutralizing antibody response 
against VP4 protein. A point mutation at position 469 (Q-L) 
indicating increased pathogenicity of porcine rotavirus 
strain, 4F in piglets was absent in the study strains [26]. 
Similar observation has been made for asymptomatic and 
symptomatic human rotavirus strains and wild type and cell 
culture adapted CDC-9 strains [13]. 
  Currently licensed rotavirus vaccines, Rotarix and 
RotaTeq are developed through serial passaging of the 89-
12 and WC-3 strains, respectively. G1 and P[8] genotypes 
are important components of both vaccines. The study 
presented here reports nucleotide / amino acid substitutions 
in the VP4 genes of serially passaged G1P[8] rotavirus 
strains. Such strains need further evaluation for attenuation 
Table 1
Amino acid substitutions in the VP4 protein.
Strain Genotype
Amino acid positions
33 46 60 104 113 162 183 189 237 377 387 389 480 586 587 600 615 616 621 625 644 672
Consensus aa V A T A N K A N L V S P Q T I V S K K T I Y
KU G1P[8] . . . . . . . . . . . . . . . . . . . . . .
Wa G1P[8] . . . . . R . S P . . . . A . . N . . . . .
DRC88 G8P[8] . . . . D R . . . . . . . A F . N . R . . .
DH396 G9P[8] . . . R . . . . . . . A F N . . . .
06361 G1P[8] . . . . . R . . . . . . . . V L N R . . . .
06361-CA G1P[8] . . R* . . R . . . . . . . . V L N R . . . .
0613158 G1P[8] . . . . . R . . . . . . . . V . N . . . . .
0613158-CA G1P[8] . V* . . . R . . . . . . . A V . N . . . . .
061060 G1P[8] . . . . . R . S . G N . . A Y . N . . . . F
61060-CA G1P[8] . . . . . . . . V* . . S* H* . V L N R . . . .
0715880 G1P[8] I . . V D R D . . . . . . A F . . . R . L .
0715880-CA G1P[8] . . . . . . . . . . . . . . V L G* R . P* . .
* Unique amino acid substitutions detected in the present study,  aa: amino acid.
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and immunogenicity as they may have implications in the 
development of newer rotavirus vaccines. 
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